Linked diaryl compounds with anticancer properties and methods of using the same

A compound having the following formula:

• wherein
• W is selected from the group consisting of —R1, —OR1, —N(R1)2, —NO2, -halogen,
• wherein
• E is selected from the group consisting of oxygen atom, sulfur atom, —N(R1)—, and —N(OR1)—;
• X is —N—, or —C(R1)—;
• Y is selected from the group consisting of —R1, -ER1, —X(R1)2, and -halogen;
• n is 0-6;
• and
• R1 is selected from the group consisting of H, substituted or unsubstituted C1-C14 alkyl, substituted or unsubstituted C1-C14 heteroalkyl, wherein 1-7 of the chain atoms are independently O, N, S, P, or B, substituted or unsubstituted C1-C14 alkenyl, substituted or unsubstituted C1-C14 heteroalkenyl, wherein 1-7 of the chain atoms are independently O, N, S, P, or B, substituted or unsubstituted C1-C14 alkynyl, substituted or unsubstituted C1-C14 heteroalkynyl, wherein 1-7 of the chain atoms are independently O, N, S, P, or B, substituted or unsubstituted C5-C14 aryl, halo, heteroaryl having 5-14 ring atoms, wherein1-8 of the ring atoms are independently O, N, S, P, or B,
• wherein
• Y1 is selected from the group consisting of —OR1, —NR1, —SR1, and —R1;
• L is selected from the group consisting of direct bond, —O—, —NH—, —O—(CH2)m—O—, —NH—(CH2)m—NH—,
• wherein
• m is 2-6;
• Q is selected from the group consisting of —OH, —SH, —NR1,
• wherein
• A is selected from the group consisting of direct covalent bond, —SO2—NH—, —NH—;
• and
• Z is selected from the group consisting of —S—, —O—, -ER1—, —CH, —N—, —NH—, —N+(R1)—, and —N(R1)—.